| The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression. | lung, |
| Alternative splicing of iodothyronine deiodinases in pituitary adenomas. Regulation by oncoprotein SF2/ASF. | pituitary, |
| Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer. | lung, |
| Identification of new splicing events regulated by the oncogenic splicing factor SRSF1 in lung cancer using novel analytical tool. | lung, |
| Using RNA-sequencing and 3-D cell cultures that mimic breast cancer, the authors identified SRSF1-regulated alternative splicing targets that are candidates for mediating SRSF1_s oncogenic functions in mammary cells. | breast, |
| The gene encoding the splicing factor SF2/ASF is a proto-oncogene. | None |
| The splicing-factor oncoprotein SF2/ASF activates mTORC1. | None |
| Arginine methylation controls the subcellular localization and functions of the oncoprotein splicing factor SF2/ASF. | None |
| Oncogenic splicing factor SRSF1 stabilizes the tumor suppressor protein p53 via RPL5, inducing cell senescence. | None |
| Splicing-factor oncoprotein SRSF1 stabilizes p53 via RPL5 and induces cellular senescence. | None |
| RRM1 domain of the splicing oncoprotein SRSF1 is required for MEK1-MAPK-ERK activation and cellular transformation. | None |
| Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer. | None |